Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 451 AL 465

Resveratrol in experimental Alzheimer's disease models: A systematic review of preclinical studies

Chen JY, Zhu Q, Zhang S, OuYang D, Lu JH.

Pharmacol Res. 2019 Dec;150:104476. doi: 10.1016/j.phrs.2019.104476. Epub 2019 Oct 9.

The roles of S-nitrosylation and S-glutathionylation in Alzheimer's disease

Dyer RR, Ford KI, Robinson RAS.

Methods Enzymol. 2019;626:499-538. doi: 10.1016/bs.mie.2019.08.004.

The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer's Disease: A Review

Ahmad SS, Khan S, Kamal MA, Wasi U.

CNS Neurol Disord Drug Targets. 2019;18(9):657-667. doi: 10.2174/1871527318666191011145941.

Significant Upregulation of Alzheimer's β-Amyloid Levels in a Living System Induced by Extracellular Elastin Polypeptides

Ma C, Su J, Sun Y, Feng Y, Shen N, Li B, Liang Y, Yang X, Wu H, Zhang H, Herrmann A, Tanzi RE, Liu K, Zhang C.

Angew Chem Int Ed Engl. 2019 Dec 16;58(51):18703-18709. doi: 10.1002/anie.201912399. Epub 2019 Nov 4.

Transcriptional Networks of Microglia in Alzheimer's Disease and Insights into Pathogenesis

Chew G, Petretto E.

Genes (Basel). 2019 Oct 12;10(10):798. doi: 10.3390/genes10100798.

The LipiDiDiet trial: what does it add to the current evidence for Fortasyn Connect in early Alzheimer's disease?

Rasmussen J.

Clin Interv Aging. 2019 Aug 15;14:1481-1492. doi: 10.2147/CIA.S211739. eCollection 2019.

Natural Compounds with Anti-BACE1 Activity as Promising Therapeutic Drugs for Treating Alzheimer's Disease

Naushad M, Durairajan SSK, Bera AK, Senapati S, Li M.

Planta Med. 2019 Nov;85(17):1316-1325. doi: 10.1055/a-1019-9819. Epub 2019 Oct 16.

Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease

Dubey T, Chinnathambi S.

Arch Biochem Biophys. 2019 Nov 15;676:108153. doi: 10.1016/j.abb.2019.108153. Epub 2019 Oct 14.

Corticotropin releasing factor-binding protein (CRF-BP) as a potential new therapeutic target in Alzheimer's disease and stress disorders

Vandael D, Gounko NV.

Transl Psychiatry. 2019 Oct 22;9(1):272. doi: 10.1038/s41398-019-0581-8.

Receptor-Interacting Protein Kinase 1 (RIPK1) as a Potential Therapeutic Target: An Overview of Its Possible Role in the Pathogenesis of Alzheimer's Disease

Chan HH, Koh RY, Lim CL, Leong CO.

Curr Alzheimer Res. 2019;16(10):907-918. doi: 10.2174/1567205016666191023102422.

Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches

Tibbo AJ, Tejeda GS, Baillie GS.

Biochem Soc Trans. 2019 Oct 31;47(5):1557-1565. doi: 10.1042/BST20190763.

Anti-Alzheimer's Materials Isolated from Marine Bio-resources: A Review

Rathnayake AU, Abuine R, Kim YJ, Byun HG.

Curr Alzheimer Res. 2019;16(10):895-906. doi: 10.2174/1567205016666191024144044.

Fundamentals of cross-seeding of amyloid proteins: an introduction

Ren B, Zhang Y, Zhang M, Liu Y, Zhang D, Gong X, Feng Z, Tang J, Chang Y, Zheng J.

J Mater Chem B. 2019 Dec 14;7(46):7267-7282. doi: 10.1039/c9tb01871a. Epub 2019 Oct 24.

Tubulin: Structure, Functions and Roles in Disease

Binarová P, Tuszynski J.

Cells. 2019 Oct 22;8(10):1294. doi: 10.3390/cells8101294.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias